Important It is possible that the main title of the report Radiation Sickness is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
acute radiation sickness
delayed radiation sickness
Summary Radiation sickness describes the harmful effects--acute, delayed, or chronic--produced by exposure to ionizing radiation. An observable effect due to radiation exposure becomes quite certain after a single dose of several hundred rads. As a rule, large doses of radiation are of concern because of their immediate effects on the body (somatic), while low doses are of concern because of the potential for possible late somatic and long-term genetic effects. The effects of radiation exposure on an individual are cumulative.
Although there is currently no treatment to repair cells that have already been damaged by radiation, the FDA has recently approved drugs that are very effective at removing radioactive elements from the body. Because the damage is irreversible, patients exposed to radiation that are experiencing symptoms should seek medical help immediately so that drugs can be administered.
Introduction The first observable cases of radiation sickness occurred after the nuclear bombing of Hiroshima and Nagasaki. Japanese doctors described an unknown disease with symptoms that "suddenly appeared in certain patients with no apparent injuries." It is now known that these first patients were suffering delayed effects of radiation exposure. Radiation sickness can result in patients with low exposure levels, such as cancer treatments, and leave them with symptoms similar to a case of the flu. However, in cases of extreme exposure caused from atomic weapons or a power plant meltdown, such as Chernobyl, the effects can be fatal.
Total dose and dose rate determine somatic or genetic effects of radiation. The units of measurement commonly used in determining radiation exposure or dose are the roentgen, the rad, and the rem. The roentgen (R) is a measure of quantity of x or gamma ionizing radiation in air. The radiation absorbed dose (rad) is the amount of energy absorbed in any substance from exposure, and applies to all types of radiation. The R and the rad are nearly equivalent in energy for practical purposes. The rem is used to correct for the observation that some types of radiation, such as neutrons, may produce more biological effect for an equivalent amount of absorbed energy; thus the rem is equal to the rad multiplied by a constant called the "quality factor". For x and gamma radiation the rem is equal to the rad. The rad and the rem are currently being replaced in the scientific nomenclature by two units that are compatible with the International System of Units, namely the gray (Gy), equal to 100 rads and the Sievert (Sv), equal to 100 rem.
Leukemia & Lymphoma Society 1311 Mamaroneck Avenue Suite 310 New York, NY 10605 Tel: (914)949-5213 Fax: (914)949-6691 Tel: (800)955-4572 Email: infocenter@LLS.org Internet: http://www.LLS.org
American Cancer Society, Inc. 1599 Clifton Road NE Atlanta, GA 30329 USA Tel: (404)320-3333 Tel: (800)227-2345 TDD: (866)228-4327 Internet: http://www.cancer.org
National Council on Radiation Protection and Measurements 7910 Woodmont Ave. Suite 800 Bethesda, MD 20814 USA Tel: (301)657-2652 Fax: (301)907-8768 Email: firstname.lastname@example.org Internet: http://www.NCRPonline.org
Rare Cancer Alliance 1649 North Pacana Way Green Valley, AZ 85614 USA Tel: (520)625-5495 Fax: (615)526-4921 Internet: http://www.rare-cancer.org
Genetic and Rare Diseases (GARD) Information Center PO Box 8126 Gaithersburg, MD 20898-8126 Tel: (301)251-4925 Fax: (301)251-4911 Tel: (888)205-2311 TDD: (888)205-3223 Internet: http://rarediseases.info.nih.gov/GARD/
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders (NORD). A copy of the complete report can be downloaded free from the NORD website for registered users. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational therapies (if available), and references from medical literature. For a full-text version of this topic, go to www.rarediseases.org and click on Rare Disease Database under "Rare Disease Information".
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email email@example.com
Last Updated: 9/15/2011 Copyright 1986, 1987, 1988, 1989, 2003, 2011 National Organization for Rare Disorders, Inc.
How this information was developed to help you make better health decisions.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.